Fred Grossman's most recent trade in Coya Therapeutics Inc was a trade of 140,562 Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 9, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Coya Therapeutics Inc | Fred Grossman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2025 | 140,562 | 140,562 | - | - | Stock Option (right to buy) | |
| Coya Therapeutics Inc | Fred Grossman | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 7.37 per share. | 11 Nov 2024 | 2,710 | 2,710 | - | 7.4 | 19,973 | Common Stock, par value $0.0001 per share |
| Coya Therapeutics Inc | Fred Grossman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 70,596 | 70,596 | - | - | Stock Option (right to buy) | |
| Coya Therapeutics Inc | Grossman Fred | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 81,819 | 81,819 | - | - | Stock Option (right to buy) | |
| Coya Therapeutics Inc | Fred Grossman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 74,069 | 74,069 | - | - | Stock Option (right to buy) | |
| Coya Therapeutics Inc | Fred Grossman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2023 | 74,069 | 74,069 | - | - | Stock Option (right to buy) |